España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sanara MedTech
SMTI
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$36.33
-0.51
-1.38%
At close: -
$36.33
0.00
0.00%
After Hours: Jan 31, 4:01 PM EDT
Get Report
Comment
Sanara MedTech (SMTI) Forecast
News
Earnings
Sanara MedTech (SMTI) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sanara MedTech (NASDAQ:SMTI) Stock
Sanara MedTech Stock (NASDAQ: SMTI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 24, 2025
Sanara MedTech Secures Exclusive U.S. License...
Benzinga Newsdesk
Thursday, January 23, 2025
HC Wainwright & Co. Reiterates Buy on Sanara ...
Benzinga Newsdesk
Wednesday, January 22, 2025
Cantor Fitzgerald Reiterates Overweight on Sa...
Benzinga Newsdesk
Tuesday, January 21, 2025
Sanara MedTech Appoints Elizabeth Taylor As C...
Benzinga Newsdesk
Sanara MedTech Announces Q4 And Full-Year 202...
Benzinga Newsdesk
Sanara MedTech Announces Exclusive License An...
Benzinga Newsdesk
Monday, December 23, 2024
HC Wainwright & Co. Initiates Coverage On San...
Benzinga Newsdesk
Thursday, September 12, 2024
Sanara Stock Gains From New US Distribution Deal With ChemoMouthPiece
Zacks
Wednesday, May 15, 2024
Cantor Fitzgerald Reiterates Overweight on Sa...
Benzinga Newsdesk
Monday, May 13, 2024
Sanara MedTech Q1 EPS $(0.21) Misses $(0.07) ...
Benzinga Newsdesk
Thursday, April 18, 2024
Sanara MedTech Entered Into $55M Non-Dilutive...
Benzinga Newsdesk
Wednesday, March 27, 2024
Cantor Fitzgerald Maintains Overweight on San...
Benzinga Newsdesk
Monday, March 25, 2024
Sanara MedTech Q4 EPS $(0.03) Beats $(0.13) Estimate, Sales $17.69M Beat $16.50M Estimate
Happy Mohamed
Earnings Scheduled For March 25, 2024
Benzinga Insights
Friday, March 22, 2024
Sanara MedTech's Earnings: A Preview
Benzinga Insights
Thursday, February 22, 2024
Sanara MedTech Sees Prelim. Q4 2023 Revenue ~...
Benzinga Newsdesk
Tuesday, February 06, 2024
Cantor Fitzgerald Reiterates Overweight on Sa...
Benzinga Newsdesk
Wednesday, January 03, 2024
Sanara Medtech Announced That Is Has Signed A...
Benzinga Newsdesk
Thursday, November 30, 2023
Sanara MedTech Inc. Announces The Publication...
Benzinga Newsdesk
Wednesday, November 15, 2023
Cantor Fitzgerald Maintains Overweight on San...
Benzinga Newsdesk
Tuesday, November 14, 2023
Sanara MedTech shares are trading higher afte...
Benzinga Newsdesk
Monday, November 13, 2023
Sanara MedTech Q3 EPS $(0.13) Up From $(0.18)...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Friday, November 10, 2023
Earnings Outlook For Sanara MedTech
Benzinga Insights
Tuesday, October 10, 2023
Sanara MedTech Announces First Sale Of ALLOCY...
Bill Haddad
Tuesday, September 26, 2023
Cantor Fitzgerald Reiterates Overweight on Sa...
Benzinga Newsdesk
Tuesday, August 22, 2023
Cantor Fitzgerald Reiterates Overweight on Sa...
Benzinga Newsdesk
Thursday, August 17, 2023
Cantor Fitzgerald Reiterates Overweight on Sa...
Benzinga Newsdesk
Monday, August 14, 2023
Sanara MedTech Q2 EPS $(0.22) Misses $(0.13) ...
Benzinga Newsdesk
Earnings Scheduled For August 14, 2023
Benzinga Insights
Wednesday, August 02, 2023
Sanara MedTech Inc. Announces The Acquisition Of Certain Assets Related To Its Collagen Products Business; The Initial Purchase Price For The Assets That Were Acquired By The Company Is $15.25M
Happy Mohamed
Monday, May 15, 2023
Sanara MedTech: Q1 Earnings Insights
Benzinga Insights
Sanara MedTech Q1 Sales $15.50M Miss $16.20M ...
Benzinga Newsdesk
Earnings Scheduled For May 15, 2023
Benzinga Insights
Monday, March 20, 2023
Sanara MedTech FY22 Revenue $45.8M, Up 90% Yo...
Bill Haddad
Earnings Scheduled For March 20, 2023
Benzinga Insights
Friday, March 17, 2023
Earnings Outlook For Sanara MedTech
Benzinga Insights
Friday, February 24, 2023
Sanara MedTech Says Co. Entered Into Sales Ag...
Michael Horton
Wednesday, February 22, 2023
Sanara MedTech Inc. Announces Unaudited Preliminary Results For Q4 And FY22; Q4 Net Revenue Of $15.3M; FY22 Net Revenue Of $45.8M
Happy Mohamed
Monday, November 14, 2022
Sanara MedTech Q3 Sales $13.00M Miss $14.70M Estimate
Michael Horton
Earnings Scheduled For November 14, 2022
Benzinga Insights
Thursday, November 03, 2022
InfuSystem and Sanara MedTech Announced Wound Therapy Partnership
Charles Gross
Monday, August 15, 2022
Sanara MedTech Q2 Sales $9.70M Beat $7.81M Estimate
Michael Horton
Earnings Scheduled For August 15, 2022
Benzinga Insights
Monday, May 16, 2022
Sanara MedTech Q1 Sales $7.80M Up From $5.01M...
Benzinga Newsdesk
Earnings Scheduled For May 16, 2022
Benzinga Insights
Monday, April 04, 2022
Sanara MedTech Inc. Announces Entry Into Merg...
Benzinga Newsdesk
Wednesday, March 30, 2022
Sanara MedTech FY21 Net Loss $8M vs Loss $4.4...
Benzinga Newsdesk
Earnings Scheduled For March 30, 2022
Benzinga Insights
Tuesday, March 29, 2022
Sanara MedTech's Earnings Outlook
Benzinga Insights
Show More
